お気にのミノーもあったし、チカチカDRSSもVAマグネットボールも見つけて大満足

Move on guys keep loving but accept the reality. Guy in black drss said"come,come abhishek se mila dun,points hand towards him,he turned and again said "come" pulled her hands. But ashnoor said plz plz and stopped him then he hugged her #abhinoor #AbhishekBajaj #AshnoorKaur

$OCUL NDA filing 4Q2026 Executive SummaryOn June 17, 2026, Ocular Therapeutix, Inc. announced aligned plans with the U.S. FDA to submit a New Drug Application (NDA) for AXPAXLI™ (an axitinib intravitreal hydrogel) to treat wet age-related macular degeneration (wet AMD). The submission is planned for the fourth quarter of 2026 under the 505(b)(2) pathway. Key Program Updates1. Wet AMD Program & AXPAXLI NDAFDA Alignment: Following a May 2026 Type C meeting, the FDA agreed to review the NDA based on a single pivotal trial. Submission Strategy: The NDA package will leverage Week 52 efficacy and safety data from the successful SOL-1 trial, supported by broad confirmatory evidence. Safety Requirements: To satisfy the FDA's requirement of a safety exposure dataset containing more than 300 patients, Ocular will conduct an interim safety analysis of the SOL-R trial in Q4 2026. Timeline: A pre-NDA meeting is scheduled for Q3 2026, with the full NDA submission targeted for Q4 2026. The 505(b)(2) pathway could potentially accelerate the review timeline by up to 60 days, positioning the drug for a potential 2027 launch. 2. Restructuring the SOL-R TrialEfficacy Data Dropped from NDA: SOL-R efficacy data is no longer part of the initial NDA submission plan. Trial Protocol Amendments: Ocular will maintain trial masking through Week 96 to evaluate new strategic secondary endpoints. This includes testing AXPAXLI's superiority against aflibercept (8mg) regarding changes in best corrected visual acuity (BCVA), alongside the prevention of fibrosis and atrophy. Updated Timeline: Topline data for the modified SOL-R trial are now expected in Q1 2028. 3. Diabetic Retinopathy (DR) Program StreamliningPrioritizing HELIOS-3: Based on strong data from prior trials and market research favoring a once-yearly treatment regimen, Ocular is streamlining its DR program. Trial Design: The program will prioritize HELIOS-3 as a single global registrational Phase 3 superiority trial. It will evaluate a once-every-12-months (Q12M) dosing regimen of AXPAXLI against a sham injection in patients with non-proliferative diabetic retinopathy (NPDR). Clinical Trial OverviewsTrialPhase / DesignPatient Population & EnrollmentKey Metrics / TimelineSOL-1 Phase 3, Double-masked, Superiority 344 treatment-naïve wet AMD patients (Randomization completed Dec 2024). Met primary endpoint at Week 36 ($p=0.0006$) and key secondary endpoint at Week 52 ($p<0.0001$). Year 2 safety data will be provided during the standard 120-day safety update. SOL-R Phase 3, Double-masked, 3-arm Non-inferiority 631 wet AMD patients (Randomization completed Dec 2025). No further enrollment. Primary endpoint is non-inferiority to aflibercept (2mg) at Week 56. Extended masking to Week 96 to evaluate new secondary superiority endpoints. Topline results expected Q1 2028. HELIOS-3 Phase 3, Double-masked, 2-arm Superiority Enrolling ~620 patients with moderately severe to severe NPDR without CI-DME. First patient randomized Nov 2025. Primary endpoint evaluates a $\ge$ 2-step change in diabetic retinopathy severity score (DRSS) at Week 56.

DRSSも有ったんですね🥹

モカDRSS神楽美鬼決済のタイミングで買えなかったから実質5,000円キャッシュバックだわ😂

ファットモカDRSS使わないけど・・ちびパニDRSSで良くない？！　使い分け出来るのかな

ファットモカDRSS 神楽&美鬼買えた🫨🫨嬉しすぎる

Idiot TKI works in DR : Completed DR Trials HELIOS: double-masked single AXPAXLI injection,t 48 weeks, 46.2% of patients receiving AXPAXLI showed 1- or 2-step improvements in the DRSS) with zero patients worsening. no patients developed (PDR) or Diabetic Macular Edema (CI-DME).

But u no see say the gul raise ihn drss??

You're right in that the dark drss has more details, but the choice of removing the zipper I think is the correct one. The dark dress has a lot of straps and joints to show how she's currently "bound" or "restraint," whereas the light dress is open and free flowing

Part - 11 Maami : edhukuda velila eduthukutu... pesama ullaye vittukoda ambi... Me : mmkkk ok maami... Maami : sari, ennada drss podra.. kelamba poriya...

オオツカにファットモカの神楽と美鬼あるの！？って思って行ったらめっちゃあった。 SR-F SR-SS DR-F DR-SS 美鬼のウッサSもあったけど、神楽のウッサは売り切れ。 それを横目に何かこの色良くない！？ってなったの選んで来ました。 ファットモカjrのDRSS、赤い感じが良さげ。 久しぶりのルアー購入

やっと届いた✨ 完全に観賞用🤩 #DRSS初音ミク

Tupac rocking a vest-beater with jeans and drss shoes is still the wildest outfit in hip-hop history!

超久しぶり #王禅寺 永井さんにご挨拶しイチロー池開始 鵜はいますが以前の獰猛さなく表層パターン楽しめました！イージーでないですが鵜の影響少なく非常に満足度高し サブロー池中層でガッツリバイト多数DRSSクランクで超久しぶりにエンジョイ 最終盤ですが今シーズン最高に楽しめました♪ 6時間34匹

QT Metal Flower Drss What better model to show off a metallic dress than an Alarune in a metal flower field 😎. Thanks for the tag Ami ☺️💙.

QT METAL FLOWERS DRSS Deep red wine petals with long black flowing skirt with sparkling with coiled vine. 🍷 In a drak fantasy ❤️ Open Inviting every 🥰

正直ここ最近モカdrssで1日遊べるな〜って時は ・ラーテル ・14.15ノブ ・SMSex（松本さんすんません） ・井野 ・19早乙女 ・26早乙女（そおちゃんごめんね） ・天照 ・24ノブ で遊び尽くせるから天照のストックは非常に嬉しい。ロスト怖くて毎度キャスト前にキスしてから飛ばしてたけどその儀式ももうしなくてええんやな。試合の時に隣の奴めちゃくちゃ引いてたからやめたかったんや。